Top 5 Drug Type | Count |
---|---|
Small molecule drug | 1 |
Top 5 Target | Count |
---|---|
calcium channel | 1 |
Target |
Mechanism cGMP-PDE inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date19 Apr 1940 |
Target |
Mechanism calcium channel stimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism L-type calcium channel blockers |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
FPL-64176 ( calcium channel ) | Heart Failure More | Discovery |
Aminophylline ( cGMP-PDE ) | - | Withdrawn |
FPL-65372 ( Proton pump ) | Peptic Ulcer More | Discontinued |
Utibapril ( ACE ) | Hypertension More | Discontinued |
Zemaphyte ( NF-κB ) | Eczema More | Discontinued |